Specificity exchangers that redirect antibodies to bacterial adhesion receptors

US6933366B2 · kind B2 · utility

Assignee

• TRIPEP AB · SE

Inventors

• Matti Sallberg · Stockholm, SE
• Jan-Ingmar Flock · Bromma, SE

Key dates

• Filing date: Feb 21, 2003
• Grant date: Aug 23, 2005
• Expiry date: Jul 18, 2023

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Specificity exchangers and methods of making and using specificity exchangers are disclosed. Specificity exchangers are useful for preventing and treating human diseases including cancer and those resulting from pathogens such as bacteria, yeast, parasites, fungus, viruses, and the like. More specifically, specificity exchangers can redirect existing antibodies in a subject to pathogens and cancer cells.